As of 2024-12-14, the EV/EBITDA ratio of ChemoCentryx Inc (CCXI) is -28.91. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CCXI's latest enterprise value is 3,689.20 mil USD. CCXI's TTM EBITDA according to its financial statements is -127.60 mil USD. Dividing these 2 quantities gives us the above CCXI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 16.8x | 15.9x |
| Forward P/E multiples | 15.2x - 21.1x | 15.5x |
| Fair Price | (26.89) - (29.75) | (27.79) |
| Upside | -151.7% - -157.2% | -153.4% |
| Date | EV/EBITDA |